NCT05454475

Brief Summary

Miniprobe endoscopic ultrasonography (mEUS) is a key diagnostic modality for gastrointestinal (GI) mucosal or submucosal lesions, requiring water infusion to eliminate intraluminal air and improve image clarity. However, the optimal water temperature for sedated mEUS remains uncertain-previous studies suggest water temperature may affect GI peristalsis, haemodynamics, image quality, and patient safety/comfort, but no research has focused on this topic in sedated mEUS. This is a prospective, multicentre, double-blind, randomized controlled study. Eligible patients (≥18 years with GI mucosal/submucosal lesions requiring sedated mEUS) are randomly assigned to three groups based on water temperature: cold water (6-10 °C), warm water (20-24 °C), and hot water (35-39 °C). The primary objectives are to evaluate the effects of different water temperatures on mEUS image quality (standardized scoring) and diagnostic accuracy. Secondary outcomes include GI peristaltic grade, haemodynamic indices (measured at 6 time points), adverse events, and patient somatic/psychological feeling, comfort, and satisfaction scores. The study aims to identify the optimal water temperature that reduces GI peristalsis, improves mEUS diagnostic performance, and ensures patient safety and comfort during sedated mEUS, providing evidence for standardized clinical practice.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
270

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 12, 2022

Completed
2 days until next milestone

Study Start

First participant enrolled

June 14, 2022

Completed
28 days until next milestone

First Posted

Study publicly available on registry

July 12, 2022

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2023

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2023

Completed
Last Updated

December 26, 2025

Status Verified

July 1, 2022

Enrollment Period

11 months

First QC Date

June 12, 2022

Last Update Submit

December 19, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • mEUS image quality

    Assessed by two independent experts (excluding the operating endoscopist) using Soon's scoring method on a 1-5 scale: 1 = air artifact obscures target lesion; 2 = air artifact severely impairs lesion size/characteristic assessment; 3 = air artifact mildly impairs lesion size/characteristic assessment; 4 = air artifact present but does not compromise lesion assessment; 5 = no air artifact with unimpaired lesion assessment. Scores 1-2 = poor, 3-4 = good, 5 = excellent.

    From examination initiation through 24 hours post-examination

  • mEUS diagnostic accuracy

    Gold standard confirmation: surgical, ESD or puncture histopathological results for patients with tissue specimens; ≥6-month clinical follow-up (based on manifestations, test results, lesion size and echogenic changes) for determining benign/malignant nature in other patients.

    Up to 6 months after mEUS examination

Secondary Outcomes (4)

  • Gastrointestinal (GI) peristaltic grade

    During mEUS examination

  • Haemodynamic indices

    At T0, T1, T2, T3, T4, and T5 time points

  • Adverse events

    Periprocedural (from anesthesia assessment to post-anesthesia wakefulness)

  • Somatic and psychological feeling scores

    Post-anesthesia recovery (Day 1)

Study Arms (3)

Low temperature group

The temperature is 6℃-10℃.

Other: Change the water injection temperature

room temperature group

The temperature is 20℃-24℃.

Other: Change the water injection temperature

Core temperature group

The temperature is 35℃-39℃.

Other: Change the water injection temperature

Interventions

Water injection is a routine procedure for endoscopy of small probe ultrasound, and our intervention is to change the water temperature and observe the effects of different water temperatures on patient safety and comfort.

Core temperature groupLow temperature grouproom temperature group

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

In the Third Xiangya Hospital of Central South University, the First Affiliated Hospital of South China University, the South China Hospital Affiliated to the University of South China, the Hunan Provincial People's Hospital, and the First People's Hospital of Changde City, patients with small probe ultrasound endoscopy under intravenous anesthesia due to gastrointestinal bulge lesions.

You may qualify if:

  • Age ≥ 18 years old;
  • Gastrointestinal (GI) mucosal or submucosal lesions detected by general endoscopy;
  • Require small-probe ultrasonic endoscopy (mEUS) under sedation for definitive diagnosis;
  • Clearly understand the study and voluntarily participate, with informed consent provided.

You may not qualify if:

  • Failure to meet the requirements for mEUS examination and anaesthesia, or need to use multiple sedative and analgesic drugs;
  • Pregnancy or breastfeeding;
  • Chronic use of opioids and benzodiazepines;
  • Structural changes in the GI tract caused by abdominal surgery;
  • Presence of mental illness;
  • Presence of lesions in the oesophagus.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

he Third Xiangya Hospital of Central South University

Changsha, Hunan, 410013, China

Location

Study Officials

  • L Tian

    The Third Xiangya Hospital of Central South University

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
associate professor

Study Record Dates

First Submitted

June 12, 2022

First Posted

July 12, 2022

Study Start

June 14, 2022

Primary Completion

May 1, 2023

Study Completion

June 30, 2023

Last Updated

December 26, 2025

Record last verified: 2022-07

Data Sharing

IPD Sharing
Will not share

There is not a plan to make IPD available.

Locations